Generics Brazil's health authority, ANVISA, has licensed the generic version of tenofovir to the official laboratory Fundacao Ezequiel Dias (Funed - run by the government of the state of Minas Gerais). This means nine million pills will begin to be produced as of next week, saving Brazil approximately 410 million reals ($244.7 million) by 2015. Currently, about 64,000 AIDS and 1,500 hepatitis patients in Brazil take tenofovir. 14 February 2011